Granules India acquires Senn Chemicals AG

11 Apr 2025 Evaluate

Granules India has completed the acquisition of Senn Chemicals AG, a Switzerland based Contract Development and Manufacturing Organization (CDMO) specializing in peptide development and manufacturing. The company has executed the acquisition through its wholly owned Indian subsidiary -- Granules Peptides which has acquired 100% of the equity of Senn Chemicals from the founding Senn family. 

With this acquisition, the company has forayed into the CDMO space, with Senn’s established CDMO business providing a strong platform for growth. The acquisition will enable the company to accelerate the development and manufacturing of GLP-1 receptor agonists and other peptide-based APIs, addressing the growing demand in antidiabetic, anti-obesity, and other next-generation therapeutic areas. Granules and Senn have already initiated joint development activities in this space, with a broader peptide API pipeline planned. The acquisition enhances the company’s global footprint and provides access to a regulated market client base and highly skilled scientific talent in Europe.

Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages.


Granules India Share Price

560.65 -5.90 (-1.04%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×